$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Invasive neurophysiological recordings in humans date back to seminal studies targeting electrocorticographic recordings from cortical areas and the cerebellum during epilepsy surgery and tumor research1. A critical milestone into further development of such recording procedure has been the introduction of the stereotactic technique that provides safe and efficient access to deep structures of the human brain2. Apart from clinical treatment, brain invasive approaches in humans provide a rather unique opportunity to study brain function in relation to recorded activity patterns modulated by external stimuli, notably the case of intra- and post-operative invasive recordings in patients undergoing deep brain stimulation (DBS) procedures. The applicability and usefulness of DBS has been addressed in various neurological and neuropsychiatric diseases from Parkinson's disease (PD) to obsessive compulsive disorder (OCD) or conditions like chronic disorders of consciousness (DOC).
In particular, DBS has been applied in the treatment of Parkinson's disease3,4,5, essential tremor6, primary/generalized segmental dystonia7,8,9, Huntington's disease10,11, treatment-resistant-depression12,13, nicotine and alcohol addiction14, Alzheimer's disease15,16, Tourette's syndrome17 and chronic disorder of consciousness (DOC)18,19,20.
Within the scope of neuropsychiatry, DBS is an approved/CE-marked treatment for obsessive compulsive disorder (OCD) targeting the anterior limb of the internal capsule (ALIC) and is in use targeting the ventral capsule/ventral striatum/ventral caudate (VC/VS),nucleus accumbens (Nac) and the subthalamic nucleus (STN)21. Regarding DBS in OCD22, recent studies emphasize the role of STN into the mechanism of compulsive checking by utilizing memory based-paradigms23,24,25.
Noteworthy, modulation of brain activity under the influence of paradigms with cognitive and emotional connotation has been emphasized in DOC26,27,28,29. Thus, DBS is highlighted not only as a prospective treatment for chronic DOC, but also as a clinical procedure that opens up the possibility of studying the modulation of subcortical activity by recording local field potentials (LFP) from central thalamic regions intra- and post- operatively.
In DBS, neurosurgical implantation of electrodes is based on the stereotactic technique that safely accounts for brain anatomical constraints, while patient's stimulation is customized through intra-operative impulse-stimulation tests. Post-operative LFP recording is possible after initial implantation of DBS electrodes and before internalization of the impulse generator. In particular, the present protocol is centered on post-operative recordings.
In combination with LFPs, simultaneous recording of cortical brain activity can be achieved for instance by non-invasive electroencephalography (EEG) or magnetoencephalography (MEG)30,31. These two non-invasive methods are supported due to its excellent time resolution. While MEG is less affected than EEG by skull effects32, EEG appears advantageous because it is less affected by artifacts caused by metallic implants and head movements and it can be used at the patient's bed-side33. By simultaneous recording of cortical-subcortical brain activity (LFP and EEG/MEG) in response to applied emotional-cognitive paradigms, different relationships between brain oscillations and behavior could be established on the basis of time-frequency coupling analyses34. In turn, such patterns could lead to prospective biomarkers of a patient's individualized cognitive and emotional states and optimization of treatment parameters considering individualized settings.
The following protocol targets invasive and non-invasive neurophysiological recording in humans for the assessment of cognitive and emotional function, specifically at the cortical and subcortical level (EEG and LFPs).
First, the neurophysiological recording steps illustrated in the video, that accompanies the present protocol, correspond to a recording with an example patient with movement disorder that performs the so called Flanker task (Example 1).
Second, steps in the protocol are discussed by focusing on the methodology of analysis and sample results taken from a published DBS example in chronic DOC26 (Example 2).
These two examples highlight the applicability of the proposed protocol to DBS-treated patients with different disorders and various experimental paradigms.